118 related articles for article (PubMed ID: 28513507)
1. Early pregnancy plasminogen activator inhibitor-1 levels in Nigerian women and its relationship with preeclampsia.
Udenze IC; Arikawe AP; Makwe CC
Niger J Clin Pract; 2017 May; 20(5):517-522. PubMed ID: 28513507
[TBL] [Abstract][Full Text] [Related]
2. A prospective cohort study on the clinical utility of second trimester mean arterial blood pressure in the prediction of late-onset preeclampsia among Nigerian women.
Udenze IC; Arikawe AP; Makwe CC; Olowoselu OF
Niger J Clin Pract; 2017 Jun; 20(6):741-745. PubMed ID: 28656930
[TBL] [Abstract][Full Text] [Related]
3. Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia.
Purwosunu Y; Sekizawa A; Koide K; Farina A; Wibowo N; Wiknjosastro GH; Okazaki S; Chiba H; Okai T
Clin Chem; 2007 Mar; 53(3):399-404. PubMed ID: 17234729
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
Nakashima A; Kobayashi T; Terao T
Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
[TBL] [Abstract][Full Text] [Related]
5. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
Estellés A; Gilabert J; Aznar J; Loskutoff DJ; Schleef RR
Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia.
Bodova KB; Biringer K; Dokus K; Ivankova J; Stasko J; Danko J
Dis Markers; 2011; 30(4):191-6. PubMed ID: 21694445
[TBL] [Abstract][Full Text] [Related]
7. Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia.
He S; Bremme K; Blombäck M
Blood Coagul Fibrinolysis; 1995 Dec; 6(8):703-8. PubMed ID: 8825219
[TBL] [Abstract][Full Text] [Related]
8. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia.
Shaarawy M; Didy HE
Int J Gynaecol Obstet; 1996 Nov; 55(2):135-9. PubMed ID: 8960994
[TBL] [Abstract][Full Text] [Related]
9. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria.
Belo L; Santos-Silva A; Rumley A; Lowe G; Pereira-Leite L; Quintanilha A; Rebelo I
BJOG; 2002 Nov; 109(11):1250-5. PubMed ID: 12452463
[TBL] [Abstract][Full Text] [Related]
10. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
Wikström AK; Nash P; Eriksson UJ; Olovsson MH
Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
[TBL] [Abstract][Full Text] [Related]
11. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
Halligan A; Bonnar J; Sheppard B; Darling M; Walshe J
Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of biochemical variables in women at risk of preeclampsia.
Chappell LC; Seed PT; Briley A; Kelly FJ; Hunt BJ; Charnock-Jones DS; Mallet AI; Poston L
Am J Obstet Gynecol; 2002 Jul; 187(1):127-36. PubMed ID: 12114900
[TBL] [Abstract][Full Text] [Related]
13. Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.
Ajibola SO; Adeyemo TA; Afolabi BB; Akanmu AS
Niger Med J; 2016; 57(4):213-6. PubMed ID: 27630384
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole.
Reith A; Booth NA; Moore NR; Cruickshank DJ; Bennett B
Br J Obstet Gynaecol; 1993 Apr; 100(4):370-4. PubMed ID: 8494839
[TBL] [Abstract][Full Text] [Related]
15. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
Adachi T; Nakabayashi M; Sakura M; Ando K
Semin Thromb Hemost; 1999; 25(5):447-50. PubMed ID: 10625200
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy.
Ayala DE; Hermida RC
Chronobiol Int; 2013 Mar; 30(1-2):233-59. PubMed ID: 23006127
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
Elzein HO; Muddathir AR; Rida M; Rayis DA; Elhassan EM; Adam I
Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
[TBL] [Abstract][Full Text] [Related]
18. Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia.
Roes EM; Sweep CG; Thomas CM; Zusterzeel PL; Geurts-Moespot A; Peters WH; Steegers EA
Am J Obstet Gynecol; 2002 Oct; 187(4):1019-25. PubMed ID: 12388999
[TBL] [Abstract][Full Text] [Related]
19. Study of plasma adrenomedullin level in normal pregnancy and preclampsia.
Senna AA; Zedan M; el-Salam GE; el-Mashad AI
Medscape J Med; 2008 Feb; 10(2):29. PubMed ID: 18382699
[TBL] [Abstract][Full Text] [Related]
20. Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia?
Kamal M; El-Khayat W
J Investig Med; 2011 Oct; 59(7):1147-50. PubMed ID: 21849906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
